SCHEMBL25747925

SCHEMBL25747925

CCN(CC)C(=O)C(=O)c1c[nH]c2cc(C)c(OC)cc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPK1 P28482 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ HTR6 P50406 1/20 0.38
▸ GABRP O00591 2/20 0.38
▸ GABRD O14764 2/20 0.38
▸ GABRA1 P14867 2/20 0.38
▸ GABRB1 P18505 2/20 0.38
▸ GABRG2 P18507 2/20 0.38
▸ GABRB3 P28472 2/20 0.38
▸ GABRA5 P31644 2/20 0.38
▸ GABRA3 P34903 2/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ GABRB2 P47870 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25747933 0.93 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL31077720 0.90 KDM4E (0.39) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25747942 0.90 KDM4E (0.39) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25424702 0.89 ALDH1A1 (0.40) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25438668 0.86 ALDH1A1 (0.38) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL31077755 0.86 MAPK14 (0.47) KDM4EMAPK1MAPK14GABRPGABRD
SCHEMBL25747875 0.86 MAPK14 (0.47) KDM4EMAPK1MAPK14GABRPGABRD
SCHEMBL31077730 0.84 MAPK14 (0.39) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25747909 0.84 MAPK14 (0.39) ALDH1A1MEN1KMT2ACYP1A2CYP2C9
SCHEMBL25424905 0.82 MAPK14 (0.39) KDM4EMAPK1MAPK14MTNR1AMTNR1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250101038-A1 COMPOUNDS Psylo Pty Ltd (AU) 2025-03-27 — — US disclosed
CN-118715204-A Compounds of formula (I) 普赛洛私人有限公司 2024-09-27 — — CN disclosed
WO-2023115166-A1 COMPOUNDS Psylo Pty Ltd (AU) 2023-06-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250101038-A1 COMPOUNDS NLN, SLC18A2, PYGB ALDH1A1 981/4885MEN1 1401/4885KMT2A 2336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback